ArticleScientific reports2025
Unleashing the biological potential of marine algal extracts against Staphylococcus aureus isolated from ready-to-eat beef products.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Methicillin-ResistantInternational journal of molecular sciences · 2026Review
- Escherichia coli O157:H7 prevalence in Upper Egypt: impacts on food safety and human Health, with a protection trial using natural antibacterial Piper cubeba.World journal of microbiology & biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Staphylococcus aureus is the causative agent of zoonotic diseases that are of increasing epidemiological importance and have significant implications for public health. One hundred fifty ready-to-eat meat product samples were collected from local shops in Qena City, Egypt, to investigate the bacteriological profile of S. aureus and evaluate the antimicrobial effects of marine algal extracts against identified S. aureus isolates in vitro. S. aureus was detected in 30.7% of the samples examined, with the highest incidence in luncheon samples. Detection of virulence genes revealed that 58.7%, 47.8%, 0%, 13%, and 0% of S. aureus isolates harbored coa, nuc, sea, seb, and sec genes. S. aureus isolates demonstrated a high level of antimicrobial resistance. Genetic analysis of antimicrobial resistance determinants revealed that 65.2% of the isolates carried the mecA gene, 72.2% harbored the vanA gene, and 33.3% contained the optrA gene. These findings indicate a significant prevalence of genetic markers associated with resistance to methicillin, vancomycin, and oxazolidinones, respectively, among the studied S. aureus isolates. In addition, these isolates produced various biofilm phenotypes. The most-produced biofilm phenotype was strong (32.6%). Luncheon meat showed the highest MRSA confirmation rate (36.4%), followed by sausage (37.5%), while burger products had the lowest confirmation rate (25.0%). Halimeda opuntia, Jania rubens, and Caulerpa racemosa marine algal extracts' antimicrobial activity was studied. The major constituent of Caulerpa racemosa extract was spathulenol, and the methanol extract of Caulerpa racemosa (1.5 mg/ml) exhibited the strongest antimicrobial activity against S. aureus. RT-PCR revealed significant downregulation of coa (98.7% reduction) and nuc (68.8% reduction) in Caulerpa racemosa extract-treated S. aureus. Algal extracts present a hopeful prospect for developing innovative antibacterial substances with great promise for application in food preservation and medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.